ASAM Annual Fellowship Research Award

The purpose of the ASAM Annual Fellowship Research Award supported by Merck is to encourage Fellows to understand and research co-morbid addiction and infectious diseases, such as Hepatitis C and HIV, in the early phases of their careers in the field of addiction medicine.  Examples may include screening and testing rates for Hepatitis C for patients started on buprenorphine; or treatment retention rates for IV drug users treated concurrently for opioid use disorder and Hepatitis C.

The award will provide one fellow with a year of research support.  

Applicants should either be currently accepted and/or enrolled in a one or two-year Addiction Medicine fellowship program with the recommendation and agreement of his/her training program director and institution.  All applicants must be ASAM members.


Applications should be limited to proposals addressing co-morbid infectious diseases, such as Hepatitis C and HIV, with addiction.


Criteria for selection will include:

•  Scientific quality of the project;
•  Relevance to the research focus as described above;
•  Qualifications and commitment of the applicant; and
•  The quality of the training environment.


One award in the amount of $40,000 to be used for salary support, for one year of research July 1, 2017 through June 30, 2018. The award is sent directly to the institution. The stipend is used directly toward the Award recipient’s salary support. Recipient cannot receive any other sizeable grants.

The award recipient will also receive a complimentary registration to the ASAM Review Course July 27-29, 2017 in Dallas Texas. ASAM will cover up to three nights lodging and roundtrip coach air fare to attend the ASAM Review Course July 27-29, 2017 in Dallas Texas ($1,500/max or Approval Required) where award winner will be recognized.  Award winner will also be encouraged to submit their research results as a poster submission for the ASAM Annual Conference in 2019 to bring visibility to their research work.

The 2017 application is now closed.

If you have any questions, please contact

This award is supported by a grant from Merck.